Michelle Arkin

Molecular Biology · 2004–2014

A researcher in the Science corpus: 3 papers; trusts 3 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom Michelle Arkin trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Philip J. Hajduk
  2. D. Schaumberg
  3. J. Wells
  4. M. Hann
  5. J. Greer
  6. D. Sullivan
  7. David K. Johnson
  8. Simone Fulda

Who trusts Michelle Arkin overall

  1. Vladimir N Uversky
  2. Alan C. Cheng
  3. Andrea L. Jochim
  4. Ryan G. Coleman

Papers from Michelle Arkin's perspective

Ordered by how strongly the researchers Michelle Arkin trusts endorse each paper. Same corpus, a different order for every researcher.

  1. An inhibitor of Bcl-2 family proteins induces regression of solid tumours (Nature)
  2. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. (Journal of Medicinal Chemistry)
  3. Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
  4. Prevalence of dry eye syndrome among US women. (American journal of ophthalmology-glaucoma)
  5. Targeting IAP proteins for therapeutic intervention in cancer (Nature reviews. Drug discovery)
  6. Can Self-Inhibitory Peptides be Derived from the Interfaces of Globular Protein-Protein Interactions?
  7. Druggable Protein Interaction Sites Are More Predisposed to Surface Pocket Formation than the Rest of the Protein Surface
  8. K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions (Nature)
  9. Implications of protein flexibility for drug discovery
  10. Unraveling hot spots in binding interfaces: progress and challenges. (Current Opinion in Structural Biology)

Their papers